Mohammed Almekhlafi Selected Research

Ts-72

12/2020

Endovascular Treatment Decision Making in Patients with Low Baseline ASPECTS: Insights from UNMASK EVT, an International Multidisciplinary Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mohammed Almekhlafi Research Topics

Disease

13	Stroke (Strokes) 04/2022 - 05/2015
11	Ischemic Stroke 05/2022 - 02/2016
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 05/2022 - 01/2021
2	Infarction (Infarctions) 01/2020 - 01/2020
1	Aneurysm (Aneurysms) 01/2021
1	Thrombosis (Thrombus) 01/2021
1	Cerebral Hemorrhage 09/2020
1	Edema (Dropsy) 01/2020
1	Pneumonia (Pneumonitis) 01/2020
1	Hemorrhagic Stroke 10/2019
1	Thromboembolism 01/2019
1	Hyperglycemia 01/2019

Drug/Important Bio-Agent (IBA)

3	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2022 - 01/2019
1	Tenecteplase FDA Link 01/2022
1	Ts-72IBA 12/2020
1	Collagenases (Collagenase)FDA Link 09/2020
1	mesoglycanIBA 01/2020
1	4- Acetamido- 4'- isothiocyanatostilbene- 2,2'- disulfonic Acid (SITS)IBA 10/2019
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	imidazole mustard (BIC)IBA 05/2015

Therapy/Procedure

12	Therapeutics 05/2022 - 02/2016
7	Thrombectomy 06/2020 - 01/2019
1	Catheters 01/2021
1	Aftercare (After-Treatment) 01/2021
1	Stents 01/2021
1	Induced Hypothermia 01/2020